Search the Newsreel

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Moderate Buy" by Brokerages

Tenaya Therapeutics (NASDAQ:TNYA) has received a consensus "Moderate Buy" rating from seven brokerages, with an average 12-month price target of $4.00. Despite this bullish sentiment, the company recently reported a quarterly loss of $0.20 per share and revenue of $1.11 million, both missing analyst …

Press Release: Tencent Music Entertainment Group Announces Second Quarter 2026 Unaudited Financial Results

Tencent Music Entertainment Group (TME) announced its unaudited financial results for the second quarter of 2026. This press release details the company's financial performance during this period. The full document would provide specific figures and business highlights.

Tencent's WorkBuddy Tops 20 Million Monthly Visits, Dominating China; Analysts Say Data Disclosure in Earnings Could Mark a Turning Point for the Stock

Tenet Healthcare (THC) Director Tammy Romo Sells 7,422 Shares

Tenet Healthcare (THC) Director Tammy Romo sold 7,422 shares on August 7, 2026, for approximately $1.95 million, reducing her total holdings to 28,284 shares. This transaction is part of a trend of 21 insider sells and zero buys over the past year, suggesting a …

Tenet Healthcare director Tammy Romo sells $1.95m stock By Investing.com

Tammy Romo, a director at Tenet Healthcare Corp. (NASDAQ:THC), sold approximately $1.95 million worth of common stock in two transactions earlier this month, involving 7,422 shares at prices between $260.83 and $264.15. These sales occurred as Tenet shares approached their 52-week high, following a …

Tenet Healthcare (NYSE:THC) Director Sells 2,500 Shares of Stock

Tenet Healthcare Director Tammy Romo sold 2,500 shares of company stock for over $652,000, reducing her position by 8.12%. This follows a previous sale of 4,922 shares. The stock price closed at $260.33, near its 52-week high, after the company reported strong quarterly earnings …

Tenax Therapeutics, Inc. (NASDAQ: TENX) Investors: Johnson Fistel Investigates Potential Securities Law Violations After Phase 3 Trial Failure; Shares Plummet Nearly 90%

Johnson Fistel, PLLP is investigating potential federal securities law violations by Tenax Therapeutics, Inc. (NASDAQ: TENX) after the company announced its Phase 3 LEVEL clinical trial failed to meet its primary and key secondary endpoints. Following this news, Tenax shares dropped by nearly 90%. …

Tenax Therapeutics (NASDAQ:TENX) Sets New 52-Week Low - Here's Why

Fastenal closes 6 cents shy of its 52-week high as volume gives only modest confirmation

FAST delivered its strongest week in the 26-week risk window, but the stock’s premium to Sharemaestro Fair Value and only 1.2x volume participation keep the read balanced.

Antengene Sets Board Meeting to Approve 2026 Interim Results

Form 8K Tenon Medical Inc For: 10 August By Investing.com

This article from Investing.com announces the filing of a Form 8K by Tenon Medical Inc for August 10th. The brief piece includes the stock symbol TNON and a minor price change. The core content is a straightforward notification of the SEC filing.

Tenet Healthcare’s (THC) Turnaround Is Working, but Can Its Growth Last?

Tenet Healthcare Corporation (NYSE:THC) has quietly become one of the strongest-performing healthcare stocks in the market, surging more than 270% over the past five years. That rally reflects a business that has changed significantly: Tenet (NYSE:THC) has expanded its ambulatory surgery platform, increased its …

Tenon Medical (TNON) launches 1-for-35 reverse stock split to lift share price

Tenon Medical (TNON) has enacted a 1-for-35 reverse stock split, effective August 10, 2026, to increase its share price and meet Nasdaq's minimum listing requirement of $1.00. Each 35 shares of common stock were combined into one, with fractional shares rounded up. The stock …

Fastenal (FAST) insider Michael Ancius plans 3,000-share Rule 144 stock sale

Fastenal Company insider Michael Ancius has filed a Rule 144 to sell 3,000 shares of common stock on August 10, 2026, with an aggregate market value of $156,000. This planned transaction is tied to a stock option exercise and will be executed through Morgan …

FASTENAL AKTIE: AI-Analysen, Prognose & Kursziel

Form 8K TEN Holdings Inc For: 10 August By Investing.com

This article reports on the filing of a Form 8K by TEN Holdings Inc. on August 10th. It indicates that the news was published at 4:12 p.m. on that day, and includes basic information about the company's stock performance.

Tencent Music Entertainment Q2 2026 Earnings Preview

* Tencent Music Entertainment (TME [https://seekingalpha.com/symbol/TME]) is scheduled to announce Q2 earnings results on Tuesday, August 11th, before market open. * The consensus EPS Estimate is $0.24 [https://seekingalpha.com/symbol/TME/earnings/estimates] (+4.3% Y/Y) and the consensus Revenue Estimate is $1.3B (+10.2% Y/Y). * Over the last 2 …

Intense Technologies Publishes Q1 FY27 Unaudited Results in Newspapers and Online

FirstEnergy Corp. stock underperforms Monday when compared to competitors

FirstEnergy Corp. (FE) stock fell 1.50% on Monday, closing at $46.76, while the broader market indices like the S&P 500 and Dow Jones Industrial Average also experienced slight declines. The company's stock is now 10.66% below its 52-week high of $52.34, reached on April …

Tenax Therapeutics Stock Dives as It Faces Heart Drug Study Setback

Tenax Therapeutics (NASDAQ: TENX) stock dropped significantly after its Phase 3 LEVEL study for oral levosimendan (TNX-103), a heart failure drug, missed its primary and key secondary endpoints. Despite this setback, subgroup analyses showed promising results in patients with greater disease severity and a …

ETFs Investing in Tencent Music Entertainment Group Sponsored ADR Class A Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Tencent Music Entertainment Group Sponsored ADR Class A stocks. The ETFs are sorted by market value and include various details such as issuer, management style, expense ratio, and performance metrics like …

Tennant (TNC) Faces A Valuation Test On Earnings Margin Pressure

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Second quarter earnings highlight margin pressure at Tennant Tennant (TNC) drew investor attention after reporting second quarter 2026 earnings with higher sales but …

Tenax Therapeutics (TENX) Stock Plummets 87% Amid Clinical Setba

Kakao Entertainment to Introduce Melon K-pop Categories at Tencent Music Awards

Kakao Entertainment will introduce two new K-pop categories, 'Global K Artist' and 'Melon Music Choice,' at the 2026 TME Live International Music Awards (TIMA) in Hong Kong on August 22-23. The 'Global K Artist' winner will be determined by a combination of Global K …

Tencent Music faces earnings test as competition intensifies By Investing.com

Tencent Music Entertainment Group is facing an earnings test amid intensifying competition, particularly from ByteDance’s Qishui Music. Analysts anticipate modest year-over-year growth for Q2 2026, with revenue expected to reach 8.85 billion yuan ($1.22 billion) and EPS at 1.56 yuan, a deceleration from previous …

Tenax Therapeutics Inc. (TENX) Stock Price | Live Quotes & Charts | NASDAQ

This article provides live quotes and charts for Tenax Therapeutics Inc. (TENX) stock, showing its current price of $1.77, a decrease of 86.83%. It notes that there are no analyst ratings or earnings information currently available for the company. The page also includes disclaimers …

Tenable Co-CEO and CFO to Present at Upcoming Investor Events

Tenable Holdings, Inc. announced that its CFO, Matt Brown, will present at the Stifel Tech Executive Summit from August 24-25, 2026, in Deer Valley, Utah. Additionally, Co-CEO Steve Vintz will present at the Piper Sandler Growth Frontiers Conference on September 16, 2026, in Nashville, …

TENX Stock Whipsaws As Traders Target Volatile Setup

TENX Stock Whipsaws As Traders Eye Volatility And Cash Pile

Tenax Therapeutics Inc. (TENX) stock has experienced extreme volatility, dropping 85.95% recently, despite holding over $117 million in cash and no debt. The company is burning through cash with significant operating losses, typical of a high-risk biotech profile. Traders are attracted to TENX for …

Tenable CFO and Co-CEO to Present in Utah and Nashville

Tenable (NASDAQ: TENB) announced that its CFO, Matt Brown, and Co-CEO, Steve Vintz, will participate in upcoming investor conferences. Matt Brown will present at the Stifel Tech Executive Summit in Deer Valley, Utah, on August 24-25, 2026, while Steve Vintz will present at the …

Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

Tenax Therapeutics announced topline results from its Phase 3 LEVEL clinical trial for TNX-103 in PH-HFpEF patients, revealing that the primary endpoint of improved 6-minute walk distance was not met. However, prespecified exploratory analyses showed significant reductions in NT-proBNP and right ventricular systolic pressure, …

Tenax Therapeutics (NASDAQ:TENX) Drops 85% as Phase 3 LEVEL Study Fails to Meet Main Endpoints

Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout

Investing.com - U.S. stock index futures edged higher on Monday, while Dow futures were little changed, as investors scaled back hopes for a breakthrough in the Middle East and looked ahead to key inflation data due later this week for fresh clues on the …

Tenax Therapeutics (TENX) Reports Phase 3 LEVEL Trial Results, F

XHLD Stock Whipsaws As Traders Target Volatile Move

TEN Holdings Inc. (XHLD) stock has experienced extreme volatility, with shares ripping from sub-$1 to over $5 before pulling back, creating a high-volatility trading setup. Despite this price action, the company's financials reveal significant losses, negative margins, and low cash on hand, indicating high …

Extendicare Inc. (TSX:EXE) Stock Declines 5.12% as Healthcare Cost Pressures and Investor Caution Weigh on Outlook